Director Maintains $17 Million Stake in OKYO Pharma Amid Positive Social‑Media Buzz
Insider holdings show a director’s steady 20%‑upward stake in OKYO Pharma, signalling confidence in its pre‑clinical biotech prospects and potential for future rallies.
3 minutes to read
